惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

N
Netflix TechBlog - Medium
I
InfoQ
Engineering at Meta
Engineering at Meta
Jina AI
Jina AI
Recent Announcements
Recent Announcements
T
The Blog of Author Tim Ferriss
P
Proofpoint News Feed
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
D
Docker
Microsoft Security Blog
Microsoft Security Blog
宝玉的分享
宝玉的分享
Last Week in AI
Last Week in AI
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
GbyAI
GbyAI
博客园 - Franky
博客园 - 聂微东
Microsoft Azure Blog
Microsoft Azure Blog
博客园 - 叶小钗
酷 壳 – CoolShell
酷 壳 – CoolShell
B
Blog RSS Feed
WordPress大学
WordPress大学
MyScale Blog
MyScale Blog
月光博客
月光博客
罗磊的独立博客

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health
Attention Turns To UnitedHealth Earnings For Signs Of Ins...
Bruce Japsen · 2026-04-15 · via Forbes - Healthcare
Virus Outbreak-Health Insurers

Next week’s UnitedHealth Group quarterly earnings are greatly anticipated for signs the health insurance giant and it rivals are getting a handle on rising costs dragging down managed care industry. This July 12, 2019, photo shows the UnitedHealthcare headquarters in Minneapolis. . (AP Photo/Jim Mone, File)

Copyright 2019 The Associated Press. All rights reserved

Next week’s UnitedHealth Group quarterly earnings are greatly anticipated for signs the health insurance giant and its rivals are getting a handle on rising costs dragging down the managed care industry.

UnitedHealth, which owns the nation’s largest health insurer in UnitedHealthcare, on Tuesday, April 21 will be the first health insurer out of the box to report first quarter earnings as the industry continues to reel from higher-than-expected medical costs.

UnitedHealth’s report will offer clues as to whether the sector may finally be turning the corner with most health plans reporting medical loss ratios north of 90%. Such a ratio, which is the percentage of premium revenue that goes toward medical costs, have risen above 90%. The industry would prefer such ratios to be before 90% in the mid 80s where the industry was less than two years ago.

But recent reports from industry analysts and other observers aren’t optimistic of a health insurer rebound.

Take a report last month from Moody’s Ratings that dubbed the health insurance industry’s outlook for this year as negative “as rising medical costs, thin margins, and regulatory pressures constrain the sector’s ability to regain sustainable profitability in 2026,” the analysis said.

In particular, Moody’s cited declines in membership “across all segments in 2025” and medical loss cost trends that remain “high and cannot be fully offset by premium increases.”

Health insurers continue to face high medical loss cost inflation that has affected virtually all health insurance segments including Medicare Advantage, Medicaid, the Affordable Care Act individual marketplace and group commercial,” Moody’s said. “Policy pricing adjustments and reimbursement rates for services provided have lagged medical inflation trends, medical loss ratios have deteriorated and EBITDA margins have declined to low to mid-single digit levels in 2025.”

The Moody’s report, however, came ahead of an announcement by the Trump administration last week saying health insurers that sell Medicare Advantage plans would get a rate hike they feared would be flat.

Instead, the Centers for Medicare & Medicaid Services (CMS) announced a 2.48% payment increase, which amounts to more than $13 billion in additional Medicare Advantage payments to private health insurers, that is much larger than a flat rate of 0.09% that was proposed in January.

The Medicare rate increase for 2027 is good news to some of the nation’s largest health insurers including UnitedHealthcare, CVS Health’s Aetna, Humana and Elevance Health, which all have been struggling to contain medical expenses of a record number of older adults enrolled in Medicare Advantage plans. Elevance Health reports its first quarter earnings April 22, Humana reports on April 29 and CVS reports on May 6.

Medicare Advantage plans contract with the federal government to provide traditional coverage available in traditional Medicare plus extra benefits and services to seniors, such as disease management and nurse help hotlines with some also offering vision, dental care and wellness programs.

“This 2.48% includes no change to the -1.53% headwind related to the unlinked chart review, which we do not believe negatively impacts our coverage universe,” Mizuho Americas research analyst Ann Hynes wrote in a note last week following CMS announcement. “As a result, we estimate MA rates in the ~+4.0% range depending on the company. This, coupled with benefit cuts, should allow MA margins to continue to expand in 2027, a positive sentiment driver for the group.”